Delivery Order SPE2DB22D3004-SPE2DB24FQN55
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Novolog 100 Unit/mL FlexPen 3mL insulin products. The $1,810.80 fixed-price delivery order has a completion date of September 27, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which serves as the primary vehicle for providing...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $5,088.58 firm fixed-price delivery order is for the supply of NovologTM 100 unit/mL FlexPen 3mL insulin pens. This order is part of a larger Indefinite Delivery Contract (IDC) between the DLA and Amerisourcebergen, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to provide a...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of NovologTM 100 unit/mL Flexpen 3mL insulin products. The $1,703.48 firm-fixed-price contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of June 28, 2024. The contract is not set aside for any specific business type. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $3,676.32 delivery order contract is for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a type of insulin medication. The contract has a firm fixed price pricing type and a period of performance extending through May 30, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,403.08 firm fixed-price delivery order is for the supply of NovologTM 100 unit/mL FlexPen 3mL, a prescription insulin product. The contract has an ultimate completion date of November 6, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,551.55, is for the delivery of Novolog 100 Unit/mL Flexpen 3mL, a type of insulin delivery device. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of NovologTM 100 Unit/mL FlexPenTM 3mL insulin syringes. The $1,225.44 Firm Fixed Price contract is a Delivery Order awarded by the Defense Logistics Agency (DLA), a defense agency. There is no set-aside designation, indicating open competition. The contract has an ultimate completion date of December 7, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of NovLog 100 unit/mL FlexPen 3mL insulin products. The contract has a ceiling value of $1,034.21 and a period of performance through June 28, 2024. It is structured as a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of NovologTM 100 unit/mL FlexPen 3mL insulin products. The contract has a ceiling value of $1,752.15 and is set to expire on June 7, 2023. This contract is a child of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of NovologⓇ 100 Unit/mL FlexPenⓇ 3mL insulin pens. The $1,089.28 firm fixed-price delivery order was placed by the Defense Logistics Agency, a defense agency, and has a completion date of June 5, 2024. The award is not associated with a set-aside program. Amerisourcebergen is a major pharmaceutical distributor that holds a $999,999,999.00 single-award Indefinite Delivery Contract with DLA...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB24FQN55Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Novolog 100 Unit/mL Flexpen 3mL insulin pens. The contract has a ceiling value of $3,111.20 and a period of performance through May 31, 2024. It is a firm fixed price delivery order contract, without any set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 with DLA Troop Support Medical through December 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 5/30/24 |